GT Biopharma, Inc. (GTBP)
0.3036
0.00 (0.00%)
USD |
NASDAQ |
Aug 25, 15:27
GT Biopharma Price : 0.3036 for Aug. 25, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 24, 2026 | 0.2900 | 0.318 | 0.2851 | 0.3058 | 644305.0 |
| Aug 21, 2026 | 0.2822 | 0.295 | 0.2821 | 0.2886 | 253343.0 |
| Aug 20, 2026 | 0.29 | 0.29 | 0.2755 | 0.282 | 197898.0 |
| Aug 19, 2026 | 0.2754 | 0.29 | 0.274 | 0.2869 | 360706.0 |
| Aug 18, 2026 | 0.285 | 0.285 | 0.269 | 0.2754 | 536014.0 |
| Aug 17, 2026 | 0.29 | 0.2929 | 0.2814 | 0.285 | 542422.0 |
| Aug 14, 2026 | 0.295 | 0.3062 | 0.2871 | 0.296 | 803639.0 |
| Aug 13, 2026 | 0.3012 | 0.305 | 0.295 | 0.2974 | 512363.0 |
| Aug 12, 2026 | 0.32 | 0.3205 | 0.3012 | 0.3021 | 560098.0 |
| Aug 11, 2026 | 0.331 | 0.3346 | 0.31 | 0.3128 | 225258.0 |
| Aug 10, 2026 | 0.3201 | 0.3317 | 0.3105 | 0.3206 | 411419.0 |
| Aug 07, 2026 | 0.301 | 0.3275 | 0.301 | 0.3201 | 570907.0 |
| Aug 06, 2026 | 0.3175 | 0.3238 | 0.3006 | 0.301 | 250250.0 |
| Aug 05, 2026 | 0.3235 | 0.332 | 0.3133 | 0.3175 | 252555.0 |
| Aug 04, 2026 | 0.31 | 0.3348 | 0.3099 | 0.3261 | 424668.0 |
| Aug 03, 2026 | 0.2914 | 0.3156 | 0.2871 | 0.3086 | 419243.0 |
| Jul 31, 2026 | 0.3108 | 0.3108 | 0.2815 | 0.2935 | 602209.0 |
| Jul 30, 2026 | 0.3099 | 0.3193 | 0.30 | 0.3078 | 457751.0 |
| Jul 29, 2026 | 0.3191 | 0.3191 | 0.2813 | 0.3018 | 662917.0 |
| Jul 28, 2026 | 0.34 | 0.34 | 0.3132 | 0.3167 | 468135.0 |
| Jul 27, 2026 | 0.3335 | 0.3379 | 0.3146 | 0.3341 | 368773.0 |
| Jul 24, 2026 | 0.35 | 0.35 | 0.322 | 0.3243 | 415794.0 |
| Jul 23, 2026 | 0.3438 | 0.3497 | 0.3251 | 0.3352 | 498709.0 |
| Jul 22, 2026 | 0.3582 | 0.3598 | 0.3407 | 0.3456 | 503210.0 |
| Jul 21, 2026 | 0.348 | 0.3665 | 0.3392 | 0.3583 | 474647.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 30.61 |
| Alnylam Pharmaceuticals, Inc. | 238.74 |
| Anika Therapeutics, Inc. | 21.44 |
| Savara, Inc. | 5.585 |
| Vericel Corp. | 43.00 |
Price Related Metrics
| Price to Book Value | 3.801 |
| Earnings Yield | -1.19K% |
| Market Cap | 13.56M |